Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 64-69

  Sugiyama, Tetsuya ^a   Shibata, Maho ^a   Kajiura, Sumiko ^a   Okuno, Takashi ^a   Tonari, Masahiro ^a   Oku, Hidehiro ^a   Ikeda, Tsunehiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; FASUDIL; N(G) NITROARGININE METHYL ESTER; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; DRUG DERIVATIVE; PROTEIN KINASE INHIBITOR; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MECHANISM; EVOKED VISUAL RESPONSE; EYE BLOOD FLOW; FLOW MEASUREMENT; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; LASER SPECKLE FLOWGRAPHY; MALE; MULTIPLE DRUG DOSE; NONHUMAN; OPTIC DISK CUP; PRIORITY JOURNAL; RABBIT; RETINA GANGLION CELL; ANIMAL; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; OPTIC DISK; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADMINISTRATION, TOPICAL; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; ENDOTHELIN-1; EVOKED POTENTIALS, VISUAL; INFUSIONS, INTRAVENOUS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; NG-NITROARGININE METHYL ESTER; OPTIC DISK; PROTEIN KINASE INHIBITORS; RABBITS; REGIONAL BLOOD FLOW; RHO-ASSOCIATED KINASES;

EID: 79952230532     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5265     Document Type: Article

References (30)

1. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177-185.
2. Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant. 2003; 18:1764-1769.
3. Cavarape A, Endlich N, Assaloni R, et al. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol. 2003;14:37-45.
4. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension. 2003;41:801-806.
5. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol. 2002;283: H2288-H2295.
6. Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phos-phorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002;22:8467-8477.
7. Wolfrum S, Dendorfer A, Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24:1842-1847.
8. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
9. Waki M, Yoshida Y, Oka T, Azuma M. Reduction of intraocular pressure by topical administration of an inhibitor of the Rho associated protein kinase. Curr Eye Res. 2001;22:470-474.
10. Honjo M, Inatani M, Kido N, et al. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch Ophthalmol. 2001;119:1171-1178.
11. Tokushige H, Inatani M, Nemoto S, et al. Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Oph-thalmol Vis Sci. 2007;48:3216-3222.
12. Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, Araie M. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol. 2008;126:309-315
13. Nishio M, Fukunaga T, Sugimoto M, et al. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes. Curr Eye Res. 2009;34:282-286.
14. Sako K, Tsuchiya M, Yonemasu Y, Asano T. HA1077, a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats. Eur J Pharmacol. 1991;209:39-43.
15. Satoh S, Suzuki Y, Harada T, et al. Possible prophylactic potential of HA1077, a Ca2 + channel antagonist and vasodilator, on chronic cerebral vasospasm. Eur J Pharmacol. 1992;220:243-248.
16. Nagata K, Kondoh Y, Satoh Y, et al. Effects of fasudil hydrochloride on cerebral blood flow in patients with chronic cerebral infarction. Clin Neuropharmacol. 1993;16:501-510.
17. Rikitake Y, Kim HH, Huang Z, et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005;36:2251-2257.
18. Okamura N, Saito M, Mori A, et al. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats. J Ocul Pharmacol Ther. 2007;23:207-212.
19. Arita R, Hotta Y, Nakao S, et al. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes. 2009;58:215-226.
20. Sugiyama T, Oku H, Ikari S, Ikeda T. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits. Invest Ophthalmol Vis Sci. 2000;41:1149-1152.
21. Goto W, Oku H, Okuno T, Sugiyama T, Ikeda T. Amelioration of endothelin-1-induced optic nerve head ischemia by topical bu-nazosin. Curr Eye Res. 2005;30:81-91
22. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60:373-383.
23. Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S. Use of the laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol. 2010;88:723-729
24. Sugiyama T, Utsumi T, Azuma I, Fujii H. Measurement of optic nerve head circulation: comparison of laser spackle and hydrogen clearance methods. Jpn J Ophthalmol. 1996;40:339-343
25. Kida T, Oku H, Sugiyama T, Ikeda T. The mechanism and change in the optic nerve head (ONH) circulation in rabbits after glucose loading. Curr Eye Res. 2001;22:95-101.
26. Okuno T, Oku H, Ikeda T. The reproducibility and sensitivity of visual evoked potential testing in rabbits. Neuro-Ophthalmol 2002;26:59-66.
27. Oku H, Sugiyama T, Kojima S, Watanabe T, Azuma I. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol. 1999;44:S74-S84.
28. Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007;68:126-131
29. Yano K, Kasawaki K, Hattori T, et al. Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model cerebral infarction. Eur J Pharmacol. 2008;594:77-83.
30. Araie M, Takase M, Sakai Y, Ishii Y, Yokoyama Y, Kitagawa M. Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment. Jpn J Ophthalmol. 1982;26:248-263.